Search Results - "WALSH, Jessica A"

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies by Baraliakos, Xenofon, Ranza, Roberto, Östör, Andrew, Ciccia, Francesco, Coates, Laura C, Rednic, Simona, Walsh, Jessica A, Douglas, Kevin, Gao, Tianming, Kato, Koji, Song, In-Ho, Ganz, Fabiana, Deodhar, Atul

“…The objective of this post-hoc analysis was to assess the efficacy and safety of upadacitinib in psoriatic arthritis (PsA) patients with axial involvement…”
Get full text

The International Map of Axial Spondyloarthritis Survey: A US Patient Perspective on Diagnosis and Burden of Disease by Magrey, Marina, Walsh, Jessica A., Flierl, Sandra, Howard, Richard A., Calheiros, Renato C., Wei, David, Khan, Muhammad A.

“…Objective Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that causes inflammation in the axial skeleton, resulting in structural damage and…”
Get full text

Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis by Walsh, Jessica A., Saffore, Christopher D., Collins, Eric B., Ostor, Andrew

“…Introduction Recent changes to treatment guidelines for ankylosing spondylitis (AS) have listed first-line advanced therapies as tumor necrosis factor (TNF),…”
Get full text

Product of the Physician Global Assessment and body surface area: A simple static measure of psoriasis severity in a longitudinal cohort by Walsh, Jessica A., MD, McFadden, Molly, MS, Woodcock, Jamie, MD, Clegg, Daniel O., MD, Helliwell, Philip, MD, Dommasch, Erica, MD, Gelfand, Joel M., MD, MSCE, Krueger, Gerald G., MD, Duffin, Kristina Callis, MD

“…Background The Psoriasis Area and Severity Index (PASI) is considered the gold standard assessment tool for psoriasis severity, but PASI is limited by its…”
Get full text

Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria by Baraliakos, Xenofon, Saffore, Christopher D., Collins, Eric B., Parikh, Bhumik, Ye, Xiaolan, Walsh, Jessica A.

“…Introduction With an increasing number of biologic/targeted synthetic disease-modifying antirheumatic drug options available for the treatment of active…”
Get full text

Correction: Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis by Walsh, Jessica A., Saffore, Christopher D., Collins, Eric B., Ostor, Andrew

Get full text

Cohort identification of axial spondyloarthritis in a large healthcare dataset: current and future methods by Walsh, Jessica A, Pei, Shaobo, Penmetsa, Gopi K, Leng, Jianwei, Cannon, Grant W, Clegg, Daniel O, Sauer, Brian C

“…Big data research is important for studying uncommon diseases in real-world settings. Most big data studies in axial spondyloarthritis (axSpA) have been…”
Get full text

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies by Kristensen, Lars Erik, Tillett, William, Nash, Peter, Coates, Laura C., Mease, Philip J., Ogdie, Alexis, Gisondi, Paolo, Ink, Barbara, Prickett, Adam R., Bajracharya, Rajan, Taieb, Vanessa, Lyris, Nikos, Lambert, Jérémy, Walsh, Jessica A.

“…Psoriatic arthritis (PsA) is a chronic inflammatory disease that causes pain and fatigue, reduces physical function, and negatively impacts health-related…”
Get full text

Minimal versus specialist equipment in the delivery of pulmonary rehabilitation: protocol for a non-inferiority randomised controlled trial by Nolan, Claire M, Walsh, Jessica A, Patel, Suhani, Barker, Ruth E, Polgar, Oliver, Maddocks, Matthew, Gao, Wei, Wilson, Rebecca, Fiorentino, Francesca, Man, William

“…IntroductionPulmonary rehabilitation (PR), an exercise and education programme for people with chronic lung disease, aims to improve exercise capacity,…”
Get full text

The Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-Fatigue) scale in patients with axial spondyloarthritis: psychometric properties and clinically meaningful thresholds for interpretation by Cella, David, de la Loge, Christine, Fofana, Fatoumata, Guo, Shien, Ellis, Alicia, Fleurinck, Carmen, Massow, Ute, Dougados, Maxime, Navarro-Compán, Victoria, Walsh, Jessica A.

“…Background Fatigue is an important symptom for most patients with axial spondyloarthritis (axSpA). The FACIT-Fatigue is a 13-item patient-reported outcome…”
Get full text

Mood disorder in idiopathic pulmonary fibrosis: response to pulmonary rehabilitation by Edwards, George D, Polgar, Oliver, Patel, Suhani, Barker, Ruth E, Walsh, Jessica A, Harvey, Jennifer, Man, William D-C, Nolan, Claire M

“…Pulmonary rehabilitation improves mood disorder in COPD, but there are limited data in idiopathic pulmonary fibrosis (IPF). The aims of this cohort study were…”
Get full text

Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors by Walsh, Jessica A., Lin, Iris, Zhao, Ruizhi, Shiff, Natalie J., Morrison, Laura, Emond, Bruno, Yu, Louise H., Schwartzbein, Samuel, Lefebvre, Patrick, Pilon, Dominic, Chakravarty, Soumya D., Mease, Philip

“…Background Treatment persistence among patients with psoriatic arthritis (PsA) is essential for achieving optimal treatment outcomes. Guselkumab, a fully human…”
Get full text

Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2 by Kiltz, Uta, Kishimoto, Mitsumasa, Walsh, Jessica A., Sampaio-Barros, Percival, Mittal, Manish, Saffore, Christopher D., Wung, Peter, Ganz, Fabiana, Biljan, Ana, Poddubnyy, Denis

“…Introduction To evaluate the effect of upadacitinib vs. placebo on health-related quality of life (HRQoL) and work productivity in patients with active…”
Get full text

Minimal clinically important difference for daily pedometer step count in COPD by Polgar, Oliver, Patel, Suhani, Walsh, Jessica A, Barker, Ruth E, Clarke, Stuart F, Man, William D-C, Nolan, Claire M

“…https://bit.ly/3ci97Jh…”
Get full text

Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap by Deodhar, Atul, Gensler, Lianne S., Magrey, Marina, Walsh, Jessica A., Winseck, Adam, Grant, Daniel, Mease, Philip J.

“…Patients with axial spondyloarthritis (axSpA) frequently report pain, stiffness, fatigue, and sleep problems, which may lead to impaired physical activity. The…”
Get full text

Treatment Satisfaction and Decision‐making from the Patient Perspective in Axial Spondyloarthritis: Real‐World Data from a Descriptive Cross‐sectional Survey Study from the ArthritisPower Registry by Nowell, William Benjamin, Gavigan, Kelly, Hunter, Theresa, Malatestinic, William N., Bolce, Rebecca J., Lisse, Jeffrey R., Himelein, Carol, Curtis, Jeffrey R., Walsh, Jessica A.

“…Objective Aims were to 1) to characterize patient decision‐making with treatment for axial spondyloarthritis (axSpA) and 2) to explore relationships among…”
Get full text

Clinical Manifestations and Diagnosis of Axial Spondyloarthritis by Walsh, Jessica A., Magrey, Marina

“…BACKGROUNDAxial spondyloarthritis (axSpA) is a chronic, rheumatic disease characterized by inflammation of the sacroiliac joint, spine, and entheses. Axial…”
Get full text

Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis by Mease, Philip, Walsh, Jessica A., Baraliakos, Xenofon, Inman, Robert, de Vlam, Kurt, Wei, James Cheng-Chung, Hunter, Theresa, Gallo, Gaia, Sandoval, David, Zhao, Fangyi, Dong, Yan, Bolce, Rebecca, Marzo-Ortega, Helena

“…Introduction Ixekizumab, a humanized interleukin-17A antibody, has shown efficacy in ankylosing spondylitis (AS), with a greater proportion of…”
Get full text

Recognizing Axial Spondyloarthritis: A Guide for Primary Care by Magrey, Marina N., Danve, Abhijeet S., Ermann, Joerg, Walsh, Jessica A.

“…Axial spondyloarthritis (axSpA) is an important cause of chronic low back pain and affects approximately 1% of the US population. The back pain associated with…”
Get full text

Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set by Walsh, Jessica A., Song, Xue, Kim, Gilwan, Park, Yujin

“…Comorbidities among US patients with ankylosing spondylitis (AS) are inadequately understood. This study compared the prevalence and incidence of comorbidities…”
Get full text